CytoMed Therapeutics Limited
+17.2% · 90d
$0.98
+0.03 (+3.08%)
After-Hours $0.92(-0.06)
News
(1)March 2026
CytoMed Therapeutics Ltd — 6-K Filing
GDTCCytoMed Therapeutics Ltd
# 🧾 What This Document Is This is a **Form 6-K**, a mandatory report that foreign companies (like this Singapore-based one) file with the U.S. SEC to share material news. It's essentially a press release and financial update wrapped into one official filing. Here, CytoMed is sharing its full-year 2
Read summaryView on SEC EDGAR
Peers in Biotechnology
VRTX#1
Vertex Pharmaceuticals Incorporated
$113.64B+0.64%
REGN#2
Regeneron Pharmaceuticals, Inc.
$78.80B-0.99%
ARGX#3
argenx SE
$49.22B+1.97%
ALNY#4
Alnylam Pharmaceuticals, Inc.
$42.61B-1.82%
ONC#5
BeOne Medicines AG
$34.75B+0.39%
INSM#6
Insmed Incorporated
$34.45B-0.37%
RPRX#7
Royalty Pharma plc
$27.86B+0.84%
BNTX#8
BioNTech SE
$23.26B-0.11%
ROIV#9
Roivant Sciences Ltd.
$20.38B+1.10%
MRNA#10
Moderna, Inc.
$20.34B-1.57%